4D Bioprinting
“Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
4D Bioprinting Market Size Growth Forecast: What to Expect by 2025?
The market size for 4D bioprinting has seen immense growth in the past few years and is projected to continue this trend. The market is set to increase from $0.09 billion in 2024 to reach $0.12 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 30.2%. Several factors have contributed to the significant growth experienced in the historical period, including an ageing population, a rise in healthcare spending, an increase in 3D bioprinting startups, a surge in R&D investments, and an escalation in chronic disease prevalence.
How Will the 4D Bioprinting Market Size Evolve and Grow by 2029?
Expectations are set for the 4D bioprinting market size to experience a surge in growth in the upcoming years. The market, which is projected to reach $0.34 billion in 2029, will grow at a compound annual growth rate (CAGR) of 29.9%. The growth during the forecast period can be ascribed to factors such as increased organ transplant demands, the rising elderly population, increasing occurrence of chronic illnesses, rising healthcare expenditure, and growing demand for personalized medicine. Prominent trends anticipated in the forecast period cover technological progress, academic-industrial ties, application of artificial intelligence, a shift towards decentralizing production, and integration with 3D imaging technologies.
View the full report here:
https://www.thebusinessresearchcompany.com/report/4d-bioprinting-global-market-report
What Drivers Are Propelling the Growth of 4D Bioprinting Market Forward?
The surge in need for organ transplants is projected to boost the expansion of the 4D bioprinting market. The procedure of organ transplantation, which entails the surgical removal of an organ or tissue from a donor, and transplanting it into a recipient who requires it due to organ failure or malfunction, sparks the necessity for organ transplants. This is crucial for preserving lives and enhancing the quality of life for those plagued by organ failure or malfunction. 4D bioprinting, in the realm of organ transplants, is foundational to the progress of regenerative medicine. It enables the accurate fabrication of intricate tissues and organs with operational capabilities, thus providing the potential to rectify the scarcity of donor organs and bolster transplant results. As an example, the Organ Procurement and Transplantation Network (OPTN), a government entity in the US, reported that in January 2024, 46,632 organ transplants were performed in 2023 using both living and deceased donors, marking an 8.7% surge relative to 2022, and a 12.7% elevation since 2021. As such, the surging demand for organ transplants is fuelling the expansion of the 4D bioprinting market. Next, the mounting demand for personalized medicine is predicted to stimulate the growth of the 4D bioprinting market. Personalized medicine is a health approach that customizes healthcare decisions, practices, interventions, and treatment methodologies to the distinctive attributes of each patient. In the context of personalized medicine, 4D bioprinting is instrumental as it facilitates the creation of clever, environmentally adaptive biological structures, tissues, and organs which can adjust to diverse environmental variations. According to the Personalized Medicine Coalition, a professional membership organization in the US, the sanction of 12 new personalized medicines in 2022 symbolized roughly 34% of all newly sanctioned therapies, denoting a substantial increase from previous years. Consequently, the mounting demand for personalized medicine is propelling the growth of the 4D bioprinting market.
Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=14235&type=smp
Which Emerging Trends Are Transforming the 4D Bioprinting Market in 2025?
Key players in the 4D bioprinting industry are strengthening their technological competencies and quickening the pace of groundbreaking advances in tissue engineering and regenerative medicine through strategic collaborations. They are also working together to boost innovation and broaden their research and development initiatives. For example, in March 2024, Poietis, a French biotechnology firm that offers 4D laser bioprinting, entered into a partnership with HVD Life Science. The goal of this collaboration is to advance the dissemination of the Next Generation Bioprinting (NGB-R) platform in Germany, and to increase availability of sophisticated bioprinting technology for researchers active in tissue engineering, regenerative medicine, and drug discovery. HVD Life Science, based in Austria, is a marketing and distribution firm with a specialization in life science solutions.
What Are the Key Segments in the 4D Bioprinting Market?
The 4D bioprinting market covered in this report is segmented –
1) By Type Of Technology: Extrusion-Based Technology, Laser-Based Technology, Inkjet-Based Technology, Other Types
2) By Application Area: Biomedical Application, Other Applications
3) By End-User: Pharmaceutical And Biotechnology Companies, Academic Research And Development, Other End-Users
Subsegments:
1) By Extrusion-Based Technology: FDM (Fused Deposition Modeling), Direct Ink Writing (DIW)
2) By Laser-Based Technology: Laser-Induced Forward Transfer (LIFT), Two-Photon Polymerization
3) By Inkjet-Based Technology: Thermal Inkjet, Piezoelectric Inkjet
4) By Other Types: Stereolithography (SLA), Digital Light Processing (DLP)
Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=14235&type=smp
Who Are the Key Players Shaping the 4D Bioprinting Market’s Competitive Landscape?
Major companies operating in the 4D bioprinting market are 3D Systems Corporation, CELLINK AB, EnvisionTEC Inc., Advanced Solutions Life Sciences, Nanoscribe, Aspect Biosystems Ltd., Aleph Farms, BioBots Inc., Sculpteo, Prellis Biologics, Rokit Healthcare, Cyfuse Biomedical, 3D Bioprinting Solutions, 4D Biomaterials Ltd., Allevi Inc., Cellenion, FluidForm, Methuselah Health, Nanofabrica, OxSyBio Ltd., Poietis S.A.S., REGEMAT 3D S.L., Replicel Life Sciences Inc., VIVAX BIO, Organovo Holdings Inc.
What Geographic Markets Are Powering Growth in the 4D Bioprinting Market?
North America was the largest region in the 4D bioprinting market in 2024. The regions covered in the 4D bioprinting market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=14235
This Report Supports:
1. Business Leaders & Investors – To identify growth opportunities, assess risks, and guide strategic decisions.
2. Manufacturers & Suppliers – To understand market trends, customer demand, and competitive positioning.
3. Policy Makers & Regulators – To track industry developments and align regulatory frameworks.
4. Consultants & Analysts – To support market entry, expansion strategies, and client advisory work.
Contact Us:
The Business Research Company
Europe – +44 7882 955267
Asia: +91 88972 63534
Americas – +1 310-496-7795
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Learn More About The Business Research Company
The Business Research Company provides in-depth research and insights through a vast collection of 15,000+ reports spanning 27 industries and over 60 geographies. Backed by 1,500,000 datasets, extensive secondary research, and expert insights from industry leaders, we equip you with the knowledge needed to stay ahead in the market.
Our flagship offering, the Global Market Model, is a leading market intelligence platform that delivers comprehensive and up-to-date forecasts to support strategic decision-making.
This release was published on openPR.
